HomePublicationPasadenaHuntington Medical Research Embarks on ‘Long COVID’ Risks

Huntington Medical Research Embarks on ‘Long COVID’ Risks

First published in the Nov. 4 print issue of the Pasadena Outlook.

Huntington Medical Research Institutes is collaborating with Huntington Hospital’s Long COVID Recovery Clinic to embark on a detailed, ongoing study of neurologic and cardiac manifestations of the increasingly recognized and often disabling “Long COVID.”

Dr. Robert Kloner

The study was announced during a recent online presentation in which Dr. Robert Kloner, HMRI chief science officer and scientific director of its Cardiovascular Institute, and Dr. Kimberly Shriner, fellow of the American College of Physicians (FACP), director of the Long COVID Recovery Clinic and director of Infectious Diseases and Prevention at Huntington Hospital, discussed PASC and how it can affect the brain (brain fog, headache, dizziness, seizures), heart (shortness of breath, heart failure, palpitations, chest pain, drop in blood pressure upon standing) and other organs of the body. The exact mechanisms for these symptoms and the true frequency and duration of Long COVID are still under investigation.

Dr. Kimberly Shriner

Shriner and Kloner emphasized the need for the medical community to proactively implement organized and deliberate measures to address the myriad challenges posed by the emergence of PASC in order to avert a potentially overwhelming burden on health care systems.
“PASC research is one example of how HMRI’s multi-disciplinary studies on the heart, brain and the vascular systems will help physicians and scientists understand the nature of this unique and new disease and provide insight into its presentations, duration, natural history, mechanisms and potential therapies,” Kloner said.
HMRI’s PASC research is funded through local foundation support.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Outlook Celebrating Charity

Most Popular

[bsa_pro_ad_space id=3]